姚高员强调，要围绕大平台、大产业，按照"一核引领、四园协同、全域成链"的产业发展空间格 局，提升产业集聚度、加速布局前沿赛道、培育标志性产品和领军企业，打造生物医药产业新增长极。 要围绕大攻关、大转化，加强源头创新能力、做优企业创新平台、加快创新成果转化、夯实高水平人才 支撑，加快开创性基础研究和应用性基础研究，以科技创新推动产业创新。要围绕大招引、大投资，紧 盯生物医药龙头企业招引和内生裂变项目培育，推动更多项目"落地生根""开花结果"。杭州将持续优化 营商环境，常态化倾听企业需求建议，谋划推进一批有针对性的"牵一发动全身"政策举措，全力构建良 好产业生态，全链条支持企业创新发展，以更加精准高效的服务助力企业深耕杭州、成长壮大。 姚高员指出，做大做强生物医药产业是因地制宜发展新质生产力的重要突破口之一。要紧紧围绕加 快打造生物医药创新高地和产业高地的目标任务，切实增强信心底气、坚持目标导向、聚焦重点问题， 清醒分析差距，努力做大做强做优生物医药产业集群，不断塑造发展新动能新优势。 5月15日，市长姚高员主持召开全市生物医药产业生态圈高质量发展工作座谈会。他强调，要认真 学习贯彻习近平总书记关于科技创新、产业 ...

STOCKHOLM, SWEDEN, May 13, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has reached a new milestone with 10,000 patients treated with the innovative nanosynthetic bone graft OssDsign Catalyst on the US market. OssDsign Catalyst is a nanosynthetic bone graft that demonstrates rapid and robust bone formation, even in poorly vascularized environments. Launched in the US in August 2021, OssDsign Catalyst has since achieved significant success in the Amer ...

STOCKHOLM, SWEDEN, April 30, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company OssDsign has notified a change of CEO during the second half of 2025. The purpose is to support the establishment of leadership with an even stronger presence and focus on the US market. OssDsign launched OssDsign Catalyst in the U.S. in August 2021. Since then, the company has undergone a strategic shift to become a pure-play orthobiologics company and has shown high double-digit growt ...